Shining a Light on Photochemistry in Flow

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology, APIs, Excipients, and Manufacturing, October 2021
Pages: 50–57

The ever-increasing interest in photochemistry has inspired the development of innovative, modular flow photochemistry reactors.

Sergey Yarochkin/Stock.adobe.com - Photochemistry has gained much recognition over the past 20 years, leading to the development of innovative, modular flow photochemistry systems.

Sergey Yarochkin/Stock.adobe.com

Advancements in technology combined with the rediscovery of new ‘reagentless’ activation methods—such as using light in photochemistry and electrons in electrochemistry—have changed the way researchers devise synthesis routes toward novel molecules and set up their experiments. Photochemistry has gained much recognition over the past 20 years, and this growing trend has led to the development of innovative, modular flow photochemistry systems that allow users to efficiently switch between chemistries.

Read this article in Pharmaceutical Technology’s October 2021 APIs, Excipients, and Manufacturing eBook.

About the author

Andrew Mansfield is flow chemistry leader at Syrris.

Article Details

Pharmaceutical Technology
eBook: APIs, Excipients, and Manufacturing, October 2021
October 2021
Pages: 50–57

Citation

When referring to this article, please cite it as A. Mansfield, “Shining a Light on Photochemistry in Flow,” Pharmaceutical Technology APIs, Excipients, and Manufacturing eBook (October 2021).

Articles in this issue
Knowledge Management
Pharmaceutical Knowledge Management: Experiences in Drug Development and Manufacturing
Shining a Light on Photochemistry in Flow
Shining a Light on Photochemistry in Flow
Predicting Tablet Potency in Continuous Manufacturing
Predicting Tablet Potency in Continuous Manufacturing
Powder Testing
Building Robust Specifications Using Powder Testing
Global Regulatory Approach to API Manufacturing
Global Regulatory Approach to API Manufacturing
Seeking Economies of Scale for Biocatalysis
Seeking Economies of Scale for Biocatalysis
API Development and Manufacturing: Advantages of Working with Small Molecules
API Development and Manufacturing: Advantages of Working with Small Molecules
Rethinking, Recalibrating, and Retooling
Recent Videos
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Orexo and Abera Partner to Develop Nasal Powder Vaccines

Feliza Mirasol
December 20th 2024
Article

The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Intertek Teams Up with CrystecPharma on Formulation and Development of Dry Powder Inhaler Products

Feliza Mirasol
December 13th 2024
Article

The partners will aim to establish a platform that enables rapid development of DPI products.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novartis Enters $2.9 Billion License Agreement with PTC Therapeutics for Huntington’s Disease Development Program

Feliza Mirasol
December 10th 2024
Article

Novartis will in-license PTC's PTC518 program, which has the potential become the first oral disease-modifying therapy for Huntington's disease.

Human head shape made from a large grid of pins connected with string. Communication technology and mental health concept | Image Credit: © ink drop - Stock.adobe.com

European Biotechs Unlocking Parkinson’s Disease

Cheryl Barton
December 9th 2024
Article

Centogene NV and ROPAD consortium publish data from a landmark study identifying genetic variants that may respond to innovative cell and gene therapies.